Investigates the measurement of intact incretin hormones and intact glucagon-like peptide 1 (GLP-1) in type 2 diabetics. Decrease in glucose-dependent insulinotropic polypeptide responses; Reduction of GLP-1; Effect of impaired GLP-1 on insulin secretion.